Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes (Q51551827)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 1999

Language	Label	Description	Also known as
English	Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes	scientific article published in October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

type 2 diabetes

0 references

0 references

author name string

A H Cincotta

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

A H Meier

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

M Cincotta

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

10

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

1683-1707

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Novel therapeutic strategies for the treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Circadian neuroendocrine role in age-related changes in body fat stores and insulin sensitivity of the male Sprague-Dawley rat.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of liver in pathophysiology of NIDDM

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Genetics of NIDDM.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

A new world syndrome of metabolic diseases with a genetic and evolutionary basis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The thrifty genotype in non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Study on lipid metabolism in obesity diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Body fat and sympathetic nerve activity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The hypothalamus and blood glucose regulation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5‐hydroxytryptamine1A receptor activation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of central neural mechanisms in the regulation of hepatic glucose metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Age- and diabetes-associated alterations in regional brain norepinephrine concentrations and adrenergic receptor populations in C57BL/KsJ mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob/ob).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effects of a Quick-Release Form of Bromocriptine (Ergoset) on Fasting and Postprandial Plasma Glucose, Insulin, Lipid, and Lipoprotein Concentrations in Obese Nondiabetic Hyperinsulinemic Women

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Prolactin: a diabetogenic hormone

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of bromocriptine on maturity onset diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Mechanisms of fatty acid-induced inhibition of glucose uptake

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The safety of bromocriptine in long-term use: a review of the literature

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Identifiers

10.1517/13543784.8.10.1683

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51551827&oldid=2276828325"